Introduction
Serum total 25-hydroxyvitamin D 3 [25(OH)D 3 ] is the major form of vitamin D in circulation, and this measure is widely used as a biomarker of vitamin D status (1) . Approximately twothirds of the US population has vitamin D insufficiency, as defined by serum 25(OH)D 3 levels ≤75 nmol/L (equivalent to <30 ng/mL) (2) . Low serum total 25(OH)D 3 levels have been associated with cognitive impairment (3, 4) and Alzheimer's disease (5, 6) in both crosssectional and longitudinal analyses. However, the total 25(OH)D 3 level in cerebrospinal fluid was not associated with neurologic diseases in the Korean population (7) . For this reason, it is unclear whether relying on serum total 25(OH)D 3 levels is a valid or optimal indicator of vitamin D status and function in the brain. It has been demonstrated in a rat model that serum and brain 25(OH)D 3 levels are correlated (8) . However, it is not known which forms of vitamin D are in the human brain. This gap in knowledge limits the ability to interpret the studies that correlate low circulating forms of 25(OH)D 3 and onset of cognitive impairment.
Unlike the advances in measurement of serum 25(OH)D 3 (9) (10) (11) , the pace of developing and standardizing assays for measurement of vitamin D and its metabolites in tissues has lagged behind. Most existing detection methods for vitamin D and its metabolites in plasma or tissues have utilized LC-MS/MS, with ionization methods ranging from electrospray ionization (ESI) (8) to atmospheric pressure photoionization (12, 13) and atmospheric pressure chemical ionization (14) . There is also variability in solvent extraction methods, including acetonitrile (8) , acetone (12, 14) , immunoaffinity extraction (15) , and dichloromethane: methanol mixture (DCM: MeOH) (13, 16) . Derivatization methods have been developed to augment the ionization efficiency of vitamin D 3 and its metabolites in order to enhance detection (8, 11, 14 2 D 3 as IS] were purchased from IsoScience. The calibration standards were prepared at a concentration of 10 ng/mL in methanol. All the stock solutions and working standards were stored at −80°C. 4-Phenyl-1,2,4-triazoline-3,5-dione (PTAD; 0.25 mg/mL) in acetonitrile was used for derivatization.
Samples and clinical application
The validation experiments were performed using commercially obtained porcine brain (Pel-Freez Biologicals). The porcine brain was manually homogenized using mortar and pestle under liquid nitrogen, aliquoted, and stored at −80°C.
This method was used to characterize vitamin D and its metabolites in a whole human brain obtained from a 54-y-old woman donor through the National Development and Research Institutes. The fresh brain was collected and shipped to the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University within 24 h after death. The brain was dissected into 8 different anatomical sections (cerebellum, medulla, pons, hypothalamus, prefrontal cortex, corpus callosum, middle frontal cortex, and middle temporal cortex) by a trained neuroscientist (TZ) and stored at −80°C until analysis. A single measure from each region was obtained. To verify that all 3 metabolites could be measured in human brain, this 
Preparation of brain samples
Brain tissues were weighted to 0.1 g and 0.5 mL of DCM:MeOH (1:1, vol:vol) was added prior to homogenization using a benchtop PowerGen 125 Fisher Scientific homogenizer. The extraction procedure used was a modification of steps used to extract vitamin D 3 from mouse brain (12) . Twenty microliters of IS solution [containing 250 ng/mL 13 C-25(OH)D 3 , 250 ng/mL d6-1,25(OH) 2 D 3 , and 500 ng/mL 13 C-VD 3 in methanol) and 0.5 mL DCM:MeOH (1:1, vol:vol) were added to the homogenized samples. After vortexing for 5 min, the samples were centrifuged at 4°C for 5 min at 13,200 rpm. The supernatant was then transferred to a glass tube. 0.5 mL methylene chloride:methanol mixture was added to resuspend the pellet, and the previous step was repeated. The supernatants were pooled together and subsequently dried under nitrogen gas (Organomation Multivap Nitrogen Evaporator) with heat (60°C). For derivatization, 200 μL of PTAD solution (0.25 mg/mL in acetonitrile) was added to the residue, followed by 10 s of vortex, and the samples were subsequently stored in a dark place (room temperature) for 1 h. The calibration standards and samples were dried under nitrogen gas again and then reconstituted in 100 µL of mobile phase (water:methanol: 1:1 vol: vol) with 20 mM methylamine and Intraday precision RSD (n = 6), % 0.1% formic acid, then centrifuged (at 13,200 rpm for 5 min), and the supernatants were pipetted into a vial with a glass insert before analysis.
Quadrupole ion trap instrumentation and conditions
The LC-MS/MS system included an Agilent series 1290 LC instrument (Agilent Technologies) coupled to a tandem quadrupole Sciex 5500 quadrupole ion trap (QTRAP) MS system. The chromatographic separation column was a C 18 analytical column (Waters Cortecs; 2.7 μm, 50 mm × 2.0 mm). The injection volume was 20 μL. Mobile phase A was 4 mM methylamine in water with 0.1% formic acid, and mobile phase B was 4 mM methylamine in methanol with 0.1% formic acid. The gradient program operated with a flow of 0.1 mL/min: 0-2 min, 50% B; 2-4 min, gradient from 50% B to 100% B; 4-25 min, 100% B. MSD (5500 QTRAP MS system) settings were as follows: ion source, positive ESI; temperature, 450°C; ion source gas 1: 50 psi; gas 2: 50 psi; curtain gas: 20 psi; collision gas: medium; ion spray voltage, 5500 V; declustering potential: 55 V; entrance potential: 4 V; collision energy: 20 V; collision cell exit potential: 10 V. The multiple reaction monitoring (MRM) transitions used are shown in Table 1 . Data were collected using Analyst software.
Validation experiments
Linearity was determined for vitamin D and its metabolites following serial dilution of a calibration standard to concentrations ranging from 5000 to 10 pg/mL. Regression coefficients were determined for each compound separately using linear regression.
The limit of detection (LOD) for vitamin D and its metabolites was determined by spiking porcine brain with serially diluted vitamin D standards ( Table 2 ). The LOD was defined as the lowest analyte concentration statistically different from 0 with a relative SD (RSD) of ≤20% over triplicate measurements.
Both intra-assay and inter-assay variability were determined for vitamin 
Quantification
The response factor (RF) of the vitamin D 3 was calculated by dividing the vitamin D 3 peak area by the IS ( 13 C-VD 3 ) peak area, followed by multiplying by the amount of IS. Similarly, the RF of the vitamin D 3 in samples was calculated by dividing the vitamin D 3 peak area by the IS peak area, followed by multiplying by the amount of IS added. The 
Statistical analysis
Linearity, slope, and regression coefficients were determined by linear regression. Student's paired t test was used for determination of LOD. All statistical analyses were performed using Microsoft Excel 2010. Results were considered statistically significant if the observed significance value was P < 0.05.
Results and Discussion

Optimization of extraction conditions
Lipids account for ∼60% of the brain's dry weight, and the composition of these lipids is very complex (15) 2.0 mg/mL) were also tested. PTAD at a concentration of 0.25 mg/mL was chosen for the maximum yield. This method required only 1 h of PTAD derivatization, which significantly decreased the sample preparation time, in contrast to an overnight step reported in prior studies (8) .
The method showed good linearity of vitamin D 3 , 25(OH)D 3 , and 1,25(OH) 2 D 3 over the physiological range (R 2 = 0.9995, 0.9968, and 0.9970, respectively) (Figure 1) .
The LOD of vitamin D 3 was 25 pg/g (Table 2 ). Compared with the few published methods measuring vitamin D 3 in tissues (19) (20) (21) , our method has a significant improvement of the LOD for vitamin D 3 . Jakobsen et al. (21) reported that the LOD of vitamin D 3 was 30 ng/100 g for 50 g of meat sample by LC. Notably, a very small amount of sample was used in our experiments, whereas a high sensitivity was achieved. Usually, samples of up to 50 g are required to extract vitamin D 3 in food or meat (21, 22 (12) . However, the limit of quantitation was 1000 pg/g in mouse brain, which is 20 times lower sensitivity than that of the current method.
Precision
The validation data are shown in Table 2 . Precision was investigated using homogenized porcine brains. Intraday precision of vitamin D 3 , 25(OH)D 3 , and 1,25(OH) 2 D 3 was characterized by an RSD of 5.0%, 4.5%, and 4.5%, respectively; interday precision was characterized by an RSD of 9.0%, 6.9%, and 10.7%, respectively.
Application to human brain
The method was successfully applied to the determination of vitamin D 3 and its metabolites in the human brain ( Table 3) . No vitamin D 3 was detected in any examined area of this single human brain. All analyzed human brain regions contained 25(OH)D 3 , with corpus callosum containing 334 pg/g compared with 158 pg/g in cerebellum. 1,25(OH) 2 D 3 was detected only in prefrontal and middle frontal cortex, and at these sites, it was present at low levels of 30 and 35 pg/g, respectively. Recent studies using derivatization with a Cookson-type regent showed 6S and 6R epimers because the derivatization regents reacted with s-cis-diene moiety from both the α and β sides (8, 13) . In this case, both of the peaks were integrated for quantification. This is the first report of low 1,25(OH) 2 D 3 concentrations in human brain. The previous study did not report 1,25(OH) 2 D 3 concentrations in mouse brain because the method was unable to detect it. This supports the need for an assay that can measure vitamin D metabolites with much lower limits of quantitation.
This method was also applied to the prefrontal cortex of a postmortem brain sample obtained from a participant in the Rush Memory and Aging Project (17) . The representative MRM chromatograms of vitamin D and its metabolites are shown in In conclusion, to the best of our knowledge, this study is the first report of the measurement of concentrations of vitamin D metabolites in human brain. This validated method can be applied to postmortem studies to obtain accurate information about the presence and role of vitamin D and metabolites in human brain and neurodegenerative diseases.
